NO117868B - - Google Patents

Download PDF

Info

Publication number
NO117868B
NO117868B NO15715365A NO15715365A NO117868B NO 117868 B NO117868 B NO 117868B NO 15715365 A NO15715365 A NO 15715365A NO 15715365 A NO15715365 A NO 15715365A NO 117868 B NO117868 B NO 117868B
Authority
NO
Norway
Prior art keywords
parts
acid
solution
dissolved
alkyl group
Prior art date
Application number
NO15715365A
Other languages
Norwegian (no)
Inventor
E Lyghounis
Original Assignee
Sits Soc It Telecom Siemens
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sits Soc It Telecom Siemens filed Critical Sits Soc It Telecom Siemens
Publication of NO117868B publication Critical patent/NO117868B/no

Links

Classifications

    • HELECTRICITY
    • H04ELECTRIC COMMUNICATION TECHNIQUE
    • H04JMULTIPLEX COMMUNICATION
    • H04J3/00Time-division multiplex systems
    • H04J3/17Time-division multiplex systems in which the transmission channel allotted to a first user may be taken away and re-allotted to a second user if the first user becomes inactive, e.g. TASI

Landscapes

  • Engineering & Computer Science (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Signal Processing (AREA)
  • Time-Division Multiplex Systems (AREA)
  • Use Of Switch Circuits For Exchanges And Methods Of Control Of Multiplex Exchanges (AREA)
  • Hydrogenated Pyridines (AREA)

Description

Fremgangsmåte til fremstilling av amider av N-alkylpiperidin-monokarbonsyre «g N-alkylpyrrolidin-«-monokarbonsyre. Process for the preparation of amides of N-alkylpiperidine-monocarboxylic acid «g N-alkylpyrrolidine-«-monocarboxylic acid.

Foreliggende oppfinnelse angår en The present invention relates to a

fremgangsmåte til fremstilling av amider method for the production of amides

av N-alkylpiperidin-monokarbonsyre og av of N-alkylpiperidine monocarboxylic acid and of

N-alkylpyrrolidin-a-monokarbonsyre, hvilke amider har de generelle formler: N-alkylpyrrolidine-α-monocarboxylic acid, which amides have the general formulas:

I disse formler betegner Ri en alkylgruppe, R- en lavere alkylgruppe eller et In these formulas Ri denotes an alkyl group, R- a lower alkyl group or et

kloratom, R:1 et hydrogenatom, en hydrok-sylgruppe, en lavere alkylgruppe eller en chlorine atom, R:1 a hydrogen atom, a hydroxyl group, a lower alkyl group or a

alkoksygruppe og Ra et hydrogenatom, et alkoxy group and Ra a hydrogen atom, et

kloratom, en lavere alkylgruppe eller en chlorine atom, a lower alkyl group or a

alkoksygruppe. Alternativt kan R2, R* og alkoxy group. Alternatively, R2, R* and

Ri alle være hydrogen i en og samme forbindelse. Karbonsyreamidgruppen kan væ-re tilknyttet piperidinringen i alfa-, beta-eller gamma-stillingen. Ri all be hydrogen in one and the same compound. The carboxylic acid amide group can be attached to the piperidine ring in the alpha, beta or gamma position.

Disse amider har vist seg å være meget These amides have been shown to be very

gode lokalanestetika med giftighet som er good local anesthetics with toxicity that is

meget liten i forhold til forbindelsenes very small compared to those of the compounds

aktivitet. Activity.

Ifølge oppfinnelsen fremstilles disse According to the invention, these are produced

forbindelser ved på kjent måte å la et pi-peridinmonokarbonsyrehalogenid eller et pyrrolidin-a-monokarbonsyrehalogenid eller et salt av en av disse forbindelser reagere med et aromatisk amin. Reaksjonen utføres fortrinsvis i et organisk oppløs-ningsmiddel og i nærvær av et overskudd av det aromatiske amin. Nitrogenatomet i den heterocykliske ring i det amid man får på denne måte alkylerer derpå under bruk av vanlige alkyleringsmidler. Det er bemer-kelsesverdig at kompliserende sidereaksjo-ner ikke inntreffer ved denne alkylering. compounds by allowing a piperidine monocarboxylic acid halide or a pyrrolidine α-monocarboxylic acid halide or a salt of one of these compounds to react with an aromatic amine in a known manner. The reaction is preferably carried out in an organic solvent and in the presence of an excess of the aromatic amine. The nitrogen atom in the heterocyclic ring in the amide obtained in this way is then alkylated using common alkylating agents. It is noteworthy that complicating side reactions do not occur with this alkylation.

De piperidin-mono- og pyrrolidin-«-monokarbonsyre-halogenider som er nød-vendig for denne reaksjon fremstilles hensiktsmessig ved å suspendere vedkommen-de syre eller dens hydroklorid i acetyl-klorid og å tilsette fosforpentaklorid til suspensjonen. Etter frafiltrering og vask-ning med et vannfritt oppløsningsmiddel er halogenet ferdig til bruk etter at det igjen er dispergert i et passende oppløs-ningsmiddel eller halogenidet kan tørres i vakuum og lagres. The piperidine mono- and pyrrolidine monocarboxylic acid halides necessary for this reaction are conveniently prepared by suspending the relevant acid or its hydrochloride in acetyl chloride and adding phosphorus pentachloride to the suspension. After filtering off and washing with an anhydrous solvent, the halogen is ready for use after it has been dispersed again in a suitable solvent or the halide can be dried in a vacuum and stored.

For terapeutisk formål brukes disse amider mest hensiktsmessig som salter med organiske eller anorganiske syrer, fortrinsvis som hydroklorider. For therapeutic purposes, these amides are most conveniently used as salts with organic or inorganic acids, preferably as hydrochlorides.

I det følgende beskrives som eksempler noen utførelsesformer for oppfinnelsen. In the following, some embodiments of the invention are described as examples.

Eksempel 1. Example 1.

170 vektdeler av hydrokloridet av pro-linklorid suspenderes i 100 deler aceton, hvorpå det tilsettes 350 deler 2-klor-6-me- 170 parts by weight of the hydrochloride of proline chloride are suspended in 100 parts of acetone, whereupon 350 parts of 2-chloro-6-me-

tylanilin. Denne tilsetning utføres raskt, og en nesten fullstendig oppløsning finner sted. Man holder reaksjonsatlandingen ko-kende i omkring 1/2 time hvorpå hydrokloridet av prolin-2-klor-6-metylanilid begyn-ner å krystallisere ut. Etter avkjøling frafiltreres bunnfallet og vaskes med aceton. For ytterligere rensning av bunnfallet opp-løses dette i vann, og oppløsningens pH-verdi innstilles på omkring 5,5 hvorpå den ekstraheres med et passende oppløsnings-middel, f. eks. eter, for å skille den led-sagende 2-klor-6-metylanilin fra oppløs-ningen. Etter fjernelse av oppløsningsmid-let behandles den tilbakeværende vandige oppløsning med trekull, og produktet utfelles med alkali. Bunnfallet frafiltreres og tørres i vakuum. 10 vektdeler av det herved erholdte rene prolin-2-klor-6-metyl-anilid oppløses i 2 volumdeler normal bu-tanol. Denne oppløsning tilsettes 5 vektdeler kaliumkarbonat og 5 deler normalt butylbromid, hvorpå man oppvarmer opp-løsningen under tilbakeløpskjøling og om-røring i 12 timer. Kaliumbromid fraskilles oppløsningen ved filtrering, og oppløsnin-gen inndampes til tørrhet. Residuet etter inndampningen oppløses i fortynnet saltsyre, behandles med trekull og felles påny med alkali. Det N-normalt-butylprolin-2-klor-6-metylanilid som utfelles herved er krystallinsk og er etter filtrering, vasking og tørring tilstrekkelig rent til å overføres til salter. tylaniline. This addition is carried out rapidly, and an almost complete dissolution takes place. The reaction mixture is kept boiling for about 1/2 hour, after which the hydrochloride of proline-2-chloro-6-methylanilide begins to crystallize out. After cooling, the precipitate is filtered off and washed with acetone. For further purification of the precipitate, this is dissolved in water, and the solution's pH value is set to around 5.5, after which it is extracted with a suitable solvent, e.g. ether, to separate the corresponding 2-chloro-6-methylaniline from the solution. After removal of the solvent, the remaining aqueous solution is treated with charcoal, and the product is precipitated with alkali. The precipitate is filtered off and dried in a vacuum. 10 parts by weight of the pure proline-2-chloro-6-methylanilide thus obtained are dissolved in 2 parts by volume of normal butanol. 5 parts by weight of potassium carbonate and 5 parts of normal butyl bromide are added to this solution, after which the solution is heated under reflux and stirring for 12 hours. Potassium bromide is separated from the solution by filtration, and the solution is evaporated to dryness. The residue after evaporation is dissolved in dilute hydrochloric acid, treated with charcoal and combined again with alkali. The N-normal-butylproline-2-chloro-6-methylanilide which is precipitated here is crystalline and, after filtration, washing and drying, is sufficiently pure to be transferred to salts.

Eksempel 2. Example 2.

184 vektdeler av pipekolinsyreklorid-hydroklorid bringes til å reagere med 363 deler 2,6-dimetylanilin på en måte lignen-de den i eksempel 1 beskrevne. Man får herved pipekolinsyre-2,6-dimetylanilid. Til 10 deler av denne forbindelse tilsettes 20 deler dietylsulfat, og blandingen holdes på dampbad i 3 timer. Etter nedkjøling til romtemperatur tilsettes 40 deler vann, og overskuddet av dietylsulfat ekstraheres ved hjelp av et passende oppløsningsmid-del, f. eks. eter. Etter at oppløsningen er befridd fra oppløsningsmiddel og dietylsulfat, behandles den med trekull og felles med alkali. Herved utfelles N-etyl-pipeko-linsyre-2,6-dimetylanilid i krystallinsk form. Bunnfallet frafiltreres, vaskes og tørres. 184 parts by weight of pipecolic acid chloride-hydrochloride are reacted with 363 parts of 2,6-dimethylaniline in a manner similar to that described in example 1. This gives pipecolic acid-2,6-dimethylanilide. To 10 parts of this compound, 20 parts of diethyl sulphate are added, and the mixture is kept on a steam bath for 3 hours. After cooling to room temperature, 40 parts of water are added, and the excess of diethyl sulphate is extracted using a suitable solvent, e.g. ether. After the solution is freed from solvent and diethyl sulfate, it is treated with charcoal and combined with alkali. This precipitates N-ethyl-pipecolic acid-2,6-dimethylanilide in crystalline form. The precipitate is filtered off, washed and dried.

Eksempel 3. Example 3.

10 vektdeler pipekolinsyre-2,6-dimetyl-anilid fremstillet som beskrevet i eksem- 10 parts by weight of pipecolic acid-2,6-dimethylanilide prepared as described in example

pel 2 oppløses i 20 volumdeler metanol, og pel 2 is dissolved in 20 parts by volume of methanol, and

oppløsningen tilsettes 10 vektdeler dimetylsulfat. Oppløsningen oppvarmes derpå under tilbakeløpskjøling i 10 timer hvorpå metanolen avdestilleres i vakuum. Bunnfallet oppløses i 40 deler vann og felles 10 parts by weight of dimethylsulphate are added to the solution. The solution is then heated under reflux for 10 hours, after which the methanol is distilled off in a vacuum. The precipitate is dissolved in 40 parts water and collected

med alkali. Den utfelte base, som i begyn-nelsen er tilbøyelig til å utfelles som en olje som senere krystalliserer, frafiltreres og vaskes. Uten å tørres oppløses derpå for-bindelsen i fortynnet saltsyre, behandles med trekull, utfelles påny, filtreres og vaskes. På denne måte får man krystallinsk N-metyl-pipekolinsyre-2,6-dimetylanilid. with alkali. The precipitated base, which initially tends to precipitate as an oil which later crystallizes, is filtered off and washed. Without drying, the compound is then dissolved in dilute hydrochloric acid, treated with charcoal, precipitated again, filtered and washed. In this way, crystalline N-methyl-pipecolic acid-2,6-dimethylanilide is obtained.

Eksempel 4. Example 4.

10 vektdeler pipekolinsyre-2,6-dimetyl-anilid fremstillet som angitt i eksempel 2 oppløses i 60 deler toluol. Oppløsningen tilsettes 6,4 deler cyklopentylbromid og 5 deler kaliumkarbonat. Etter 10 timers opp-varmning under tilbakeløpskjøling med stadig omrøring filtreres oppløsningen, og filtratet inndampes til tørrhet. Residuet oppløses i fortynnet saltsyre, behandles med trekull og felles med alkali. Herved får man krystallinsk N-cyklopentyl-pipeko-linsyre-2,6-dimetylanilid. 10 parts by weight of pipecolic acid-2,6-dimethylanilide prepared as indicated in example 2 are dissolved in 60 parts of toluene. 6.4 parts of cyclopentyl bromide and 5 parts of potassium carbonate are added to the solution. After 10 hours of heating under reflux with constant stirring, the solution is filtered, and the filtrate is evaporated to dryness. The residue is dissolved in dilute hydrochloric acid, treated with charcoal and precipitated with alkali. This gives crystalline N-cyclopentyl-pipecolic acid-2,6-dimethylanilide.

Eksempel 5. Example 5.

184 vektdeler pipekolinsyreklorid-hydroklorid bringes på en måte tilsvaren-de den i eksempel 1 beskrevne til å reagere med 579 deler 2,6-dimetyl-4-normalt-butoksyanilin. Man får pipekolinsyre-2,6-dimejtyl-4-normalt-butoksyanilid. 10 deler av denne forbindelse oppløses i 20 volumdeler metylalkohol. Til den erholdte opp-løsning tilsettes 4,2 vektdeler dimetylsulfat og 4 deler kaliumkarbonat. Blandingen oppvarmes under tilbakeløpskjøling og oppvarmes i 10 timer, avkjøles, filtreres og inndampes til tørrhet. Residuet opp-løses i fortynnet saltsyre, behandles med trekull og felles påny med alkali, hvorved man får N-metyl-pipekolinsyre-2,6-dimetyl-4-normalt-butoksyanilid. 184 parts by weight of pipecolic acid chloride hydrochloride are brought to react with 579 parts of 2,6-dimethyl-4-normal-butoxyaniline in a manner corresponding to that described in example 1. Pipecolic acid-2,6-dimethyl-4-normal-butoxyanilide is obtained. 10 parts of this compound are dissolved in 20 parts by volume of methyl alcohol. To the solution obtained, 4.2 parts by weight of dimethyl sulphate and 4 parts of potassium carbonate are added. The mixture is heated under reflux and heated for 10 hours, cooled, filtered and evaporated to dryness. The residue is dissolved in dilute hydrochloric acid, treated with charcoal and combined again with alkali, whereby N-methyl-pipecolic acid-2,6-dimethyl-4-normal-butoxyanilide is obtained.

Eksempel 6. Example 6.

184 vektdeler nipekotinsyreklorid-hydroklorid bringes på en måte tilsvaren-. de den i eksempel 1 beskrevne til å reagere med 263 deler 2-etyl-anilin, hvorved man får nipekotinsyre-2-etylanilid. 10 deler av denne forbindelse oppløses i 20 volumdeler isopropylalkohol. Til den erholdte oppløs-ning tilsettes 5,3 vektdeler isopropylbromid 184 parts by weight of nipecotinic acid chloride-hydrochloride is in a way brought to the equivalent. those described in example 1 to react with 263 parts of 2-ethylaniline, whereby nipecotic acid-2-ethylanilide is obtained. 10 parts of this compound are dissolved in 20 parts by volume of isopropyl alcohol. 5.3 parts by weight of isopropyl bromide are added to the solution obtained

og 5 deler kaliumkarbonat. Blandingen oppvarmes under tilbakeløpskjøling og om-røring i 12 timer, filtreres og inndampes til tørrhet. Etter oppløsning av residuet i fortynnet saltsyre og utfelning påny med alkali fåes N-isopropyl-nipekotinsyre-2-etylanilid i form av den frie base. and 5 parts potassium carbonate. The mixture is heated under reflux and stirring for 12 hours, filtered and evaporated to dryness. After dissolving the residue in dilute hydrochloric acid and precipitation again with alkali, N-isopropyl-nipecotic acid-2-ethylanilide is obtained in the form of the free base.

Eksempel 7. Example 7.

184 vektdeler av nipekotinsyreklorid-hydroklorid bringes på en måte tilsvaren-de den i eksempel 1 beskrevne til å reagere med 2,6-dimetyl-4-hydroksyanilid. Man får nipekotinsyre-2,6-dimetyl-4-hydr-oksyanilid. 10 deler av denne forbindelse oppløses i 60 deler toluol og 6,6 deler cyklo-heksylbromid, og den erholdte oppløsning tilsettes 5 deler kaliumkarbonat. Etter opp-varmning under tilbakeløpskjøling og om-røring i 10 timer nedkjøles oppløsningen, filtreres og inndampes. Residuet oppløses i fortynnet saltsyre, behandles med trekull og felles påny med alkali. Man får krystallinsk N-cykloheksyl-nipekotinsyre-2,6-dimetyl-4-hydroksyanilid. 184 parts by weight of nipecotic acid chloride-hydrochloride are brought to react with 2,6-dimethyl-4-hydroxyanilide in a manner corresponding to that described in example 1. Nipecotic acid-2,6-dimethyl-4-hydroxyanilide is obtained. 10 parts of this compound are dissolved in 60 parts of toluene and 6.6 parts of cyclohexyl bromide, and 5 parts of potassium carbonate are added to the resulting solution. After heating under reflux and stirring for 10 hours, the solution is cooled, filtered and evaporated. The residue is dissolved in dilute hydrochloric acid, treated with charcoal and combined again with alkali. Crystalline N-cyclohexyl-nipecotic acid-2,6-dimethyl-4-hydroxyanilide is obtained.

Eksempel 8. Example 8.

184 vektdeler av isonipekotinsyreklorid-hydroklorid bringes på en måte tilsvaren-de den i eksempel 1 beskrevne til å reagere med 279 deler anilin, hvorved man får isonipekotinsyreanilid. 10 deler av denne forbindelse oppløses i 20 volumdeler metanol, og til den erholdte oppløsning tilsettes 6,2 vektdeler dimetylsulfat og 5,5 deler kaliumkarbonat. Blandingen oppvarmes under tilbakeløpskjøling og omrøring i 10 timer, nedkjøles, filtreres og inndampes. Etter oppløsning av residuet i fortynnet saltsyre, behandling av oppløsningen med trekull og felning påny med alkali får man 184 parts by weight of isonipecotinic acid chloride-hydrochloride are brought to react with 279 parts of aniline in a manner corresponding to that described in example 1, whereby isonipecotinic acid anilide is obtained. 10 parts of this compound are dissolved in 20 parts by volume of methanol, and 6.2 parts by weight of dimethyl sulphate and 5.5 parts of potassium carbonate are added to the resulting solution. The mixture is heated under reflux and stirring for 10 hours, cooled, filtered and evaporated. After dissolution of the residue in dilute hydrochloric acid, treatment of the solution with charcoal and precipitation again with alkali, one obtains

N-metylisonipekotinsyreanilid i krystallinsk form. N-methylisonipecotin anilide in crystalline form.

Claims (1)

Fremgangsmåte til fremstilling av amider av N-alkyl-piperidin-monokarbonsyre, og av N-alkylpyrrolidin-a-monokarbonsyre, med de generelle formler:Process for the preparation of amides of N-alkyl-piperidine-monocarboxylic acid, and of N-alkylpyrrolidine-a-monocarboxylic acid, with the general formulas: hvor karbonsyreamidgruppen er tilknyttet piperidinringen i alfa-, beta- e-ller gamma-stillingen, og i hvilke Ri betegner en alkylgruppe, R^ en lavere alkylgruppe eller et kloratom, Ra et hydrogenatom, en hydrok-sylgruppe, en lavere alkylgruppe eller en alkoksygruppe, R-t betegner et hydrogenatom, et kloratom, en lavere alkylgruppe eller en alkoksygruppe, eller alternativt Ri-, R:s og Ri alle kan være hydrogen i en og samme forbindelse, karakterisert ved at man lar et piperidinmonokarbonsyrehalo-genid eller et pyrrolidin-«-monokarbonsyrehalogenid reagere med et aromatisk amin i hvilket Rl>, R:i og R4 har den foran angitte betydning, hvorpå man ved hjelp av i og for seg kjente metoder alkylerer nitrogenatomet i den heterocykliske ring.where the carboxylic acid amide group is linked to the piperidine ring in the alpha, beta or gamma position, and in which Ri denotes an alkyl group, R^ a lower alkyl group or a chlorine atom, Ra a hydrogen atom, a hydroxyl group, a lower alkyl group or an alkoxy group . -monocarbonic acid halide react with an aromatic amine in which Rl>, R:i and R4 have the meaning indicated above, whereupon the nitrogen atom in the heterocyclic ring is alkylated by means of methods known per se.
NO15715365A 1964-03-24 1965-03-10 NO117868B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT654664 1964-03-24

Publications (1)

Publication Number Publication Date
NO117868B true NO117868B (en) 1969-10-06

Family

ID=11121186

Family Applications (1)

Application Number Title Priority Date Filing Date
NO15715365A NO117868B (en) 1964-03-24 1965-03-10

Country Status (8)

Country Link
AT (1) AT265376B (en)
BE (1) BE661547A (en)
CH (1) CH427922A (en)
DE (1) DE1267288B (en)
FR (1) FR1438322A (en)
GB (1) GB1078483A (en)
NL (1) NL148211B (en)
NO (1) NO117868B (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE604025C (en) * 1931-11-14 1934-10-13 Standard Elek Zitaets Ges A G Circuit arrangement for telecommunications, especially telephone systems with two-way traffic
DE1072656B (en) * 1957-09-26 1960-01-07 Western Electric Company Incorporated New York, N Y (V St A) , and Carl Brandt Henry Feldman Belleair Clearwater, Fla. (V St A) I Time Division Multiplexed Telephone System

Also Published As

Publication number Publication date
CH427922A (en) 1967-01-15
GB1078483A (en) 1967-08-09
NL148211B (en) 1975-12-15
FR1438322A (en) 1966-05-13
AT265376B (en) 1968-10-10
BE661547A (en) 1965-07-16
NL6502645A (en) 1965-09-27
DE1267288B (en) 1968-05-02

Similar Documents

Publication Publication Date Title
US3419560A (en) 1-aminoalkyl 2-aryl indanes and tetrahydronaphthalenes
NO123148B (en)
US2792399A (en) Anilides of heterocyclic compounds
NO117374B (en)
PL184767B1 (en) Novel method of obtaining monohydrate of ropivakin hydrochloride
NO117868B (en)
US2838509A (en) 9-aminoalkyl-9-xanthenecarboxamides
US2933530A (en) Method of producing quaternary ammonium compounds
NO124430B (en)
NO139920B (en) PROCEDURE FOR THE PREPARATION OF 2,5-DISUBSTITUTED BENZAMIDES
US3103515A (en) Basic esters of i-benzoxacycloalkane-
SU609464A3 (en) Method of obtaining n-(2-pyrrolidinylmethyl)-benzamides or salts thereof
US2880209A (en) Piperazine quaternary salts having parasitical activity and method of making
JP2009535327A (en) Ropivacaine hydrochloride anhydride and its preparation
NO143084B (en) DEPARTMENT FOR SHALL REMOVAL OF MARINE CANCER, SPECIAL ANTARCTIC KRILL.
US2734920A (en) New chemical compounds and their
DE69737529T2 (en) Preparation of 1-Butyl-4-piperidin-methylmethylamine
SU786883A3 (en) Method of preparing (omega-aminoalkoxy)-bibenzyls or their salts
NO135092B (en)
US3378592A (en) Process for the production of 3, 4-dihydroxybenzyloxyaminehydrobromide
US2535971A (en) 1-carbalkoxy-4-substituted piperazines
US2980683A (en) Process for preparing beta-substitutedethyl piperazines
SU449485A3 (en) The method of obtaining-substituted esters of 1,2,3,6-tetrahydro-4-pyridylmethylcarboxylic acid
US3128276A (en) Optionally alpha-substituted 1-amino-2,3, or 4-(cyclohexyl/- phenyl) methylpiperidines and precursors
US3198835A (en) Pyrenyl methyl tertiary amino amines